{"id":43094,"date":"2018-09-25T12:30:21","date_gmt":"2018-09-25T11:30:21","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=43094"},"modified":"2018-10-02T14:14:01","modified_gmt":"2018-10-02T13:14:01","slug":"richard-smith-improving-evaluation-regulation-medical-devices","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/","title":{"rendered":"Richard Smith: Improving the evaluation and regulation of medical devices"},"content":{"rendered":"<p><a href=\"https:\/\/blogs.bmj.com\/bmj\/files\/2014\/12\/richard_smith_2014.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-33037\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2014\/12\/richard_smith_2014-150x150.jpg\" alt=\"richard_smith_2014\" width=\"128\" height=\"128\" \/><\/a><span style=\"font-weight: 400\">Earlier this month the Scottish government ordered an immediate halt to the use of vaginal mesh <a href=\"https:\/\/www.bbc.com\/news\/uk-scotland-scotland-politics-45498019\">after mesh had contributed to a woman\u2019s death<\/a> in Edinburgh in August.<\/span><span style=\"font-weight: 400\">\u00a0The death followed years of <a href=\"https:\/\/www.bmj.com\/content\/359\/bmj.j5515\">accumulating evidence<\/a> of the dangers of vaginal mesh.<\/span><span style=\"font-weight: 400\">\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Women undergoing hysteroscopic sterilisation with the \u201cEssure\u201d device have <a href=\"https:\/\/www.bmj.com\/content\/351\/bmj.h5162\">10 times the risk of needing reoperation<\/a> compared with women undergoing laparoscopic sterilisation,<\/span><span style=\"font-weight: 400\">\u00a0and last year the device was removed from the European market. These are just two examples among multiple failures that raise questions about how medical devices reach the market, and a meeting in Bristol earlier this month discussed how systems for allowing medical devices onto the market might be improved.<\/span> <span style=\"font-weight: 400\">In the same week <a href=\"https:\/\/www.thetimes.co.uk\/article\/matt-hancock-endorses-untested-health-app-3xq0qcl0x\">the Secretary of State for Health said<\/a> that GP at Hand, an app that uses artificial intelligence to assess symptoms and offers video and telephone consultations with GPs, should be available across England before the NHS has completed its evaluation of the device.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Regulatory approval of medical devices is generally much less onerous than approval of drugs. In the US devices judged as low risk can be approved on the grounds of being as safe and effective as existing devices, some of which may have been approved back before clinical evidence was required. In Europe some 50 \u201cnotified bodies\u201d can approve devices on sometimes little more than a narrative review of published reports. Although the Medicines and Healthcare Products Regulatory Agency (MHRA) oversees the UK notifying bodies, the required evidence to let the device be marketed for clinical use is much less rigorous than in the drug industry. Randomised controlled trials are not required. The problem can be summarised by saying that manufacturers chose the methods of evaluation and the outcomes they will use, allowing lots of scope for potentially unsafe products to reach market.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Camilla Fleetcroft from the MHRA explained how the European Union is trying to tighten up approval systems, but Carl Heneghan, director of the Centre for Evidence Based Medicine who has studied processes for regulating medical devices, described the proposals as a hundred pages of smokescreen.<\/span><\/p>\n<p><span style=\"font-weight: 400\">There is acceptance that the system used for drugs does not work for medical devices, where there is often continuing development of the device and it may well require surgery to install the device and so some learning by surgeons. There is even less regulation of surgical procedures themselves. But there are ideas on what a better system for evaluating devices could look like. Peter McCulloch, professor of surgical science in Oxford, described how the <a href=\"http:\/\/www.ideal-collaboration.net\/\">IDEAL<\/a> (Idea, Development, Exploration, Assessment, Long term study) system for evaluating surgical innovations can be adapted for devices.<\/span><span style=\"font-weight: 400\">\u00a0IDEAL answers a series of questions: what is the it (the surgical innovation)?, stage 1; have we perfected it? stage 2a; can we agree on what it is and who should get it?, stage 2b; is it better than current practice? stage 3; and are there any surprises? Stage 4.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Medical devices would require, said McCulloch, a stage 0, which would be prehuman studies. Stage 2a would probably be redundant, and stage 2b only partially relevant. Stage 3 is important and would preferably be answered with randomised trials with specified and agreed outcomes or large scale studies. Everybody at the meeting agreed that stage 4 requires that for all implantable devices, like vaginal mesh, registers should be established with every patient being registered to allow long term surveillance. Preferably the registers should be independent of manufacturers, but they are expensive to maintain. Yet, as with vaginal mesh and other implanted devices, it may take many years for serious problems to emerge.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Many devices are produced by small companies, and, as Edward Draper, chief executive officer of Ortheia Ltd, explained, conducting trials is expensive and sometimes beyond the means of small companies. There has to be a trade-off among the needs of patients, regulators, companies, purchasing authorities, and health professionals. Getting the trade-off right may not be easy. Ted Lystig, director of corporate biostatistics for Medtronic (one of the largest medical device companies), predicted that in coming years \u201creal world evidence\u201d derived from administrative and claims data and electronic health records would become steadily more important, complementing not replacing evidence from clinical trials. Scott Gottlieb, the director of the Food and Drug Administration, has predicted that in a world of personalised medicine and patients with multiple conditions real world evidence may overtake clinical trials as the most important evidence in making decisions on new drugs and devices. This is scary to some when the underlying data are of questionable quality and the methods used to try and minimise bias are complex and unfamiliar.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The main thrust of the meeting, which was funded by the MRC Hubs for Trials Methodology Network, was to try and encourage the use of generic core outcome sets in making decisions on the regulation of devices. Kerry Avery, a senior lecturer on health services research in Bristol, reported how a review of 42 studies of leadless pacemakers (pacemakers that are implanted directly into the patient\u2019s heart, avoiding the need for leads between the pacemaker and the heart, which are prone to infection) found some 2500 different individual outcomes reported. Heneghan told the meeting how the <a href=\"http:\/\/compare-trials.org\/\">COMPARE study<\/a> of 67 randomised trials in the top five medical journals found 354 outcomes specified in protocols but not reported and 357 that were not specified but were reported.\u00a0<\/span><span style=\"font-weight: 400\">This switching of outcomes opens up the possibility of very misleading results.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The <a href=\"http:\/\/www.comet-initiative.org\/\">COMET<\/a> (Core Outcome Measures in Effectiveness Trials) Initiative aims to encourage the development and uptake of core outcome sets.<\/span><span style=\"font-weight: 400\">\u00a0Core outcome sets are a scientifically agreed minimum data set that are selected by relevant stakeholders to use in all trials of specific conditions. Paula Williamson, professor of medical statistics at the MRC north West Hub for Trials Methodological Research, described how agreeing on core outcome sets increases consistency across trials, makes systematic reviews more meaningful, increases the likelihood that important outcomes are measured, and reduces selective reporting. <\/span><\/p>\n<p><span style=\"font-weight: 400\">Who should be part of agreeing outcomes? At the moment it\u2019s health professionals, patients, and those who do the research, but users of the research, particularly regulators, should probably be included. As trials have the ultimate aim of improving patient care patients, argued Williamson, are the most important voice. Yet trials, she reported, measure about only half of the outcomes that matter to patients. Currently, core outcomes sets are designed for Phase 3 randomised controlled trials and not used in early phase studies or in the studies developed to being new devices onto the market. The role of using surrogate outcomes in the earlier phase studies was considered as that could link to the core outcome sets used in phase 3 trials and improve the understanding of the &#8220;life cycle&#8221; of a device. <\/span><\/p>\n<p><span style=\"font-weight: 400\">All those at the conference discussed <a href=\"https:\/\/journals.lww.com\/annalsofsurgery\/Fulltext\/2018\/01000\/Magnetic_Surgery__Results_From_First_Prospective.16.aspx\">a study<\/a> from <\/span><i><span style=\"font-weight: 400\">Annals of Surgery<\/span><\/i><span style=\"font-weight: 400\">, the world\u2019s leading general surgical journal we were told, that evaluated the Magnetic Surgical System, in which surgeons performing a laparoscopic cholecystectomy place a metal clip on the gallbladder, and an external magnet then allows external retraction and mobilisation of the gallbladder. <\/span><span style=\"font-weight: 400\">This avoids the need for an extra entry point for an assistant to retract the gallbladder, so potentially reducing \u201cincisional pain, scarring, infection, and bowel and vascular injuries.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">The study reported a \u201cclinical trial,\u201d but it was actually a series of 50 patients, most of whom were young and relatively thin and did not have scarred gallbladders. Outcomes included things like \u201cdevice ease of use\u201d (\u201cyes\u201d in all 50 operations) and \u201cdevice malfunction\u201d (\u201cno\u201d in all 50 operations), and some things that would matter to patients like \u201cpain scores\u201d and \u201cexternal abdominal wall evaluation\u201d six hours after the operation (\u201cnormal\u201d in all 50).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Despite having no comparison group, not being big enough to measure \u201cincisional pain, scarring, infection, and bowel and vascular injuries,\u201d being conducted in a low risk group, and having results that felt \u201ctoo good to be true,\u201d the study is said to show that the device is \u201csafe and effective.\u201d The device is \u201calready cleared for commercialalization by the Food and Drug Administration,\u201d so there was a feeling at the meeting that the study was primarily intended to encourage uptake among surgeons, \u201cwho love new toys.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">The Bristol Biomedical Research Centre Surgical Innovation theme funded by the National Institute for Health Research is working to address the issues of selection, measurement, and reporting of outcomes for devices and surgical procedures, and let us hope that they can make the progress that is badly needed. <\/span><\/p>\n<p><span style=\"font-weight: 400\">I came away from the meeting worried that evaluation and regulation of medical devices is inadequate, convinced that there are better ways than are currently used to evaluate and regulate medical devices and that core outcome sets with the lead being taken by patients would be a step forward, a supporter of COMET, and depressed at the standards of the world\u2019s leading general surgical journal and the gullibility of surgeons.<\/span><\/p>\n<p><em style=\"font-size: 1rem\"><strong>Richard Smith<\/strong>\u00a0was the editor of <\/em>The BMJ<em style=\"font-size: 1rem\"> until 2004.<\/em><\/p>\n<p><span style=\"font-weight: 400\"><strong>Competing interest:<\/strong> RS spoke at the meeting, on the failures associated with current ways of publishing reports of surgical innovations, and paid his own expenses but was given a free lunch.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Earlier this month the Scottish government ordered an immediate halt to the use of vaginal mesh after mesh had contributed to a woman\u2019s death in Edinburgh in August.\u00a0The death followed [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":38364,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[955],"tags":[],"class_list":["post-43094","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-richard-smith"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Richard Smith: Improving the evaluation and regulation of medical devices - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Richard Smith: Improving the evaluation and regulation of medical devices - The BMJ\" \/>\n<meta property=\"og:description\" content=\"Earlier this month the Scottish government ordered an immediate halt to the use of vaginal mesh after mesh had contributed to a woman\u2019s death in Edinburgh in August.\u00a0The death followed [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-25T11:30:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-02T13:14:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Richard-Smith.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"Richard Smith: Improving the evaluation and regulation of medical devices\",\"datePublished\":\"2018-09-25T11:30:21+00:00\",\"dateModified\":\"2018-10-02T13:14:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/\"},\"wordCount\":1528,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Richard-Smith.jpg\",\"articleSection\":[\"Richard Smith\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/\",\"name\":\"Richard Smith: Improving the evaluation and regulation of medical devices - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Richard-Smith.jpg\",\"datePublished\":\"2018-09-25T11:30:21+00:00\",\"dateModified\":\"2018-10-02T13:14:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Richard-Smith.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2017\\\/02\\\/Richard-Smith.jpg\",\"width\":540,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/09\\\/25\\\/richard-smith-improving-evaluation-regulation-medical-devices\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Richard Smith: Improving the evaluation and regulation of medical devices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Richard Smith: Improving the evaluation and regulation of medical devices - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/","og_locale":"en_US","og_type":"article","og_title":"Richard Smith: Improving the evaluation and regulation of medical devices - The BMJ","og_description":"Earlier this month the Scottish government ordered an immediate halt to the use of vaginal mesh after mesh had contributed to a woman\u2019s death in Edinburgh in August.\u00a0The death followed [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2018-09-25T11:30:21+00:00","article_modified_time":"2018-10-02T13:14:01+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Richard-Smith.jpg","type":"image\/jpeg"}],"author":"BMJ","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"BMJ","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"Richard Smith: Improving the evaluation and regulation of medical devices","datePublished":"2018-09-25T11:30:21+00:00","dateModified":"2018-10-02T13:14:01+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/"},"wordCount":1528,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Richard-Smith.jpg","articleSection":["Richard Smith"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/","url":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/","name":"Richard Smith: Improving the evaluation and regulation of medical devices - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Richard-Smith.jpg","datePublished":"2018-09-25T11:30:21+00:00","dateModified":"2018-10-02T13:14:01+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Richard-Smith.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2017\/02\/Richard-Smith.jpg","width":540,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/09\/25\/richard-smith-improving-evaluation-regulation-medical-devices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Richard Smith: Improving the evaluation and regulation of medical devices"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmj\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/43094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=43094"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/43094\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/38364"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=43094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=43094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=43094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}